357 related articles for article (PubMed ID: 19854621)
1. High remission rates from an initial ultra-high risk state for psychosis.
Simon AE; Umbricht D
Schizophr Res; 2010 Feb; 116(2-3):168-72. PubMed ID: 19854621
[TBL] [Abstract][Full Text] [Related]
2. Transition and remission in adolescents at ultra-high risk for psychosis.
Ziermans TB; Schothorst PF; Sprong M; van Engeland H
Schizophr Res; 2011 Mar; 126(1-3):58-64. PubMed ID: 21095104
[TBL] [Abstract][Full Text] [Related]
3. Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state.
de Wit S; Schothorst PF; Oranje B; Ziermans TB; Durston S; Kahn RS
Eur Neuropsychopharmacol; 2014 Jun; 24(6):865-73. PubMed ID: 24636460
[TBL] [Abstract][Full Text] [Related]
4. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
[TBL] [Abstract][Full Text] [Related]
5. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?
Nelson B; Yuen K; Yung AR
Schizophr Res; 2011 Jan; 125(1):62-8. PubMed ID: 21074975
[TBL] [Abstract][Full Text] [Related]
6. Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome.
Simon AE; Grädel M; Cattapan-Ludewig K; Gruber K; Ballinari P; Roth B; Umbricht D
Schizophr Res; 2012 Dec; 142(1-3):108-15. PubMed ID: 23025995
[TBL] [Abstract][Full Text] [Related]
7. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
[TBL] [Abstract][Full Text] [Related]
9. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
[TBL] [Abstract][Full Text] [Related]
10. Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents.
Armando M; Pontillo M; De Crescenzo F; Mazzone L; Monducci E; Lo Cascio N; Santonastaso O; Pucciarini ML; Vicari S; Schimmelmann BG; Schultze-Lutter F
Schizophr Res; 2015 Dec; 169(1-3):186-192. PubMed ID: 26526751
[TBL] [Abstract][Full Text] [Related]
11. Ultra high-risk state for psychosis and non-transition: a systematic review.
Simon AE; Velthorst E; Nieman DH; Linszen D; Umbricht D; de Haan L
Schizophr Res; 2011 Oct; 132(1):8-17. PubMed ID: 21784618
[TBL] [Abstract][Full Text] [Related]
12. Salivary cortisol in early psychosis: New findings and meta-analysis.
Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
[TBL] [Abstract][Full Text] [Related]
13. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people.
Yung AR; Stanford C; Cosgrave E; Killackey E; Phillips L; Nelson B; McGorry PD
Schizophr Res; 2006 May; 84(1):57-66. PubMed ID: 16630707
[TBL] [Abstract][Full Text] [Related]
14. Borderline personality features and development of psychosis in an 'ultra high risk' (UHR) population: a case control study.
Thompson A; Nelson B; Bechdolf A; Chanen AM; Domingues I; McDougall E; Yung AR
Early Interv Psychiatry; 2012 Aug; 6(3):247-55. PubMed ID: 22672502
[TBL] [Abstract][Full Text] [Related]
15. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.
Armando M; Girardi P; Vicari S; Menghini D; Digilio MC; Pontillo M; Saba R; Mazzone L; Lin A; Klier CM; Schäfer MR; Amminger GP
Schizophr Res; 2012 Aug; 139(1-3):151-6. PubMed ID: 22627123
[TBL] [Abstract][Full Text] [Related]
16. Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis.
Takahashi T; Wood SJ; Yung AR; Phillips LJ; Soulsby B; McGorry PD; Tanino R; Zhou SY; Suzuki M; Velakoulis D; Pantelis C
Schizophr Res; 2009 Jun; 111(1-3):94-102. PubMed ID: 19349150
[TBL] [Abstract][Full Text] [Related]
17. Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms.
Schultze-Lutter F; Klosterkötter J; Ruhrmann S
Schizophr Res; 2014 Apr; 154(1-3):100-6. PubMed ID: 24613572
[TBL] [Abstract][Full Text] [Related]
18. Checking the predictive accuracy of basic symptoms against ultra high-risk criteria and testing of a multivariable prediction model: Evidence from a prospective three-year observational study of persons at clinical high-risk for psychosis.
Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
Eur Psychiatry; 2017 Sep; 45():27-35. PubMed ID: 28728092
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
Nelson B; Yuen HP; Wood SJ; Lin A; Spiliotacopoulos D; Bruxner A; Broussard C; Simmons M; Foley DL; Brewer WJ; Francey SM; Amminger GP; Thompson A; McGorry PD; Yung AR
JAMA Psychiatry; 2013 Aug; 70(8):793-802. PubMed ID: 23739772
[TBL] [Abstract][Full Text] [Related]
20. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
